Investigating Potential Mechanisms of Obesity by Metabolomics
News Jul 13, 2012
Obesity is a serious health problem with an increased risk of several common diseases including diabetes, cardiovascular disease, and cancer. Metabolomics is an emerging analytical technique for systemic determination of metabolite profiles, which is useful for understanding the biochemical changes in obesity or related diseases both in individual organs and at the organism level. Increasingly, this technology has been applied to the study of obesity, complementing transcriptomics and/or proteomics analyses. Indeed, the alterations of metabolites in biofluids/tissues are direct indicators of variations in physiology or pathology. In this paper, we will examine the obesity-related alterations in significant metabolites that have been identified by metabolomics as well as their metabolic pathway associations. Issues concerning the screening of biologically significant metabolites related to obesity will also be discussed.
The full article is published online in the Journal of Biomedicine and Biotechnology and is free to access.
Retrained Enzyme is Biocatalysis MilestoneNews
TU Graz researchers managed for the first time ever to ‘retrain’ an enzyme to build ring-shaped molecular structures instead of performing its natural task of reducing double bonds. The work was published in Angewandte Chemie, and is relevant for the production of pharmaceuticals and plant protection products.
Laser Pulses and Fluorescence Enable Metabolite ViewingNews
In the search for new sources of drugs, biodegradables and biofuels scientists have come to realize that life itself could be the solution, using natural metabolites produced by bacteria to produce vital compounds like penicillin. Identifying which cells are most useful for this goal has proved a huge challenge, but a new system using fluorescence and lasers has enabled metabolite viewing in real time in algae cells.READ MORE
Comments | 0 ADD COMMENT
12th International Conference on Advancements in Bioinformatics and Drug Discovery
Nov 26 - Nov 27, 2018